Schering Health Care Ltd - Zoekresultaten

Verenigde Staten - Engels - NLM (National Library of Medicine)

foradil- formoterol fumarate capsule

physicians total care, inc. - formoterol fumarate (unii: p3t5qa5j9n) (formoterol - unii:5zz84gcw8b) - formoterol fumarate 12 ug - foradil aerolizer is indicated for the treatment of asthma and in the prevention of bronchospasm only as concomitant therapy with a long-term asthma control medication, such as an inhaled corticosteroid, in adults and children 5 years of age and older with reversible obstructive airways disease, including patients with symptoms of nocturnal asthma. long-acting beta2 -adrenergic agonists (laba), such as formoterol, the active ingredient in foradil aerolizer, increase the risk of asthma-related death (see warnings). use of foradil aerolizer for the treatment of asthma without concomitant use of a long-term asthma control medication, such as an inhaled corticosteroid, is contraindicated. use foradil aerolizer only as additional therapy for patients with asthma who are currently taking but are inadequately controlled on a long-term asthma control medication, such as an inhaled corticosteroid. once asthma control is achieved and maintained, assess the patient at regular intervals and step down therapy (e.g

Verenigde Staten - Engels - NLM (National Library of Medicine)

ribavirin- ribavirin capsule

american health packaging - ribavirin (unii: 49717awg6k) (ribavirin - unii:49717awg6k) - ribavirin 200 mg - ribavirin capsules, usp in combination with interferon alfa-2b (nonpegylated) is indicated for the treatment of chronic hepatitis c (chc) in patients 3 years of age and older with compensated liver disease [see warnings and precautions ( 5.9, 5.10), and use in specific populations ( 8.4)]. the following points should be considered when initiating ribavirin capsules, usp combination therapy with intron a ® : - these indications are based on achieving undetectable hcv-rna after treatment for 24 or 48 weeks and maintaining a sustained virologic response (svr) 24 weeks after the last dose. - patients with the following characteristics are less likely to benefit from retreatment after failing a course of therapy: previous nonresponse, previous pegylated interferon treatment, significant bridging fibrosis or cirrhosis, and genotype 1 infection [see clinical studies ( 14) ]. - no safety and efficacy data are available for treatment of longer than one year. ribavirin capsules combination therapy is contraindicated i

Verenigde Staten - Engels - NLM (National Library of Medicine)

proventil hfa- albuterol sulfate aerosol, metered

physicians total care, inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol sulfate 108 ug - proventil hfa inhalation aerosol is indicated in adults and children 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm. proventil hfa inhalation aerosol is contraindicated in patients with a history of hypersensitivity to albuterol or any other proventil hfa components.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

temodal temozolomide 180 mg capsules sachet

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 180 mg - capsule, hard - excipient ingredients: tartaric acid; lactose; iron oxide yellow; titanium dioxide; silicon dioxide; gelatin; sodium lauryl sulfate; sodium starch glycollate; iron oxide red; stearic acid; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; simethicone - temodal capsules are indicated for the treatment of : patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

temodal temozolomide 140 mg capsules sachet

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 140 mg - capsule, hard - excipient ingredients: lactose; sodium starch glycollate; sodium lauryl sulfate; stearic acid; indigo carmine; gelatin; tartaric acid; silicon dioxide; titanium dioxide; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of : patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

temodal temozolomide 180 mg capsules bottle

merck sharp & dohme (australia) pty ltd - temozolomide -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

temodal temozolomide 140 mg capsules bottle

merck sharp & dohme (australia) pty ltd - temozolomide -